
News|Articles|May 1, 2004
- Pharmaceutical Technology-05-01-2004
- Volume 2004 Supplement
- Issue 3
Perspectives on Aseptic Guidance A Critical Review of FDA's 2003 Draft Guidance and a Proposed Alternative
Author(s)James P. Agalloco
FDA's draft guidance on aseptic processing contains some inherent difficulties, including unrealistic expectations of sterility and microbial quantification, an absence of harmonization with international rules, and failure to support new technologies or a risk-based approach. The authors propose a science-based alternative.
Advertisement
Articles in this issue
about 22 years ago
Implementing Total Organic Carbon Analysis for Cleaning Validationabout 22 years ago
The Future of Aseptic Processing?An Updateabout 22 years ago
Analysis of Environmental Microbiology Data from Cleanroom SamplesAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
Pharma Fundamentals: Hold Times in Biopharmaceuticals
5




